Log In
person
GRAIL Inc
GRAL
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Cancer Detection Test |
Genetic, Genomic, and Sequencing Kits
These companies manufacture genetic, genomic, assay, and sequencing test kits.
|
75M | 80.55% |
| Cancer Detection Test |
Diagnostic Test R&D Services for Pharmaceutical Customers
These companies provide diagnostic test research and development services for pharmaceutical companies engaged in clinical studies and research.
|
18.11M | 19.45% |
| keyboard_arrow_down |
Cancer Detection Test
Genetic, Genomic, and Sequencing Kits
|
75M | 80.55% |
| keyboard_arrow_right |
These companies manufacture genetic, genomic, assay, and sequencing test kits.
|
||
| keyboard_arrow_down |
Cancer Detection Test
Diagnostic Test R&D Services for Pharmaceutical Customers
|
18.11M | 19.45% |
| keyboard_arrow_right |
These companies provide diagnostic test research and development services for pharmaceutical companies engaged in clinical studies and research.
|
||